How have AWKNF shares performed in 2024?

Awakn Life Sciences' stock was trading at $0.1012 on January 1st, 2024. Since then, AWKNF shares have increased by 12.1% and is now trading at $0.1134. View the best growth stocks for 2024 here .

Are investors shorting Awakn Life Sciences?

Awakn Life Sciences saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,000 shares, a drop of 9.1% from the March 15th total of 1,100 shares. Based on an average trading volume of 15,900 shares, the days-to-cover ratio is presently 0.1 days. View Awakn Life Sciences' Short Interest .

How do I buy shares of Awakn Life Sciences?

Shares of AWKNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:AWKNF

Awakn Life Sciences (AWKNF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free AWKNF Stock Alerts

$0.11

+0.01 (+9.67%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.11
▼
$0.15
50-Day Range: $0.08
▼
$0.16
52-Week Range: $0.04
▼
$0.36

Volume: 11,440 shs
Average Volume: 20,321 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines Short Interest

Get Awakn Life Sciences alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Awakn Life Sciences Stock (OTCMKTS:AWKNF)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

AWKNF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AWKNF Stock News Headlines

April 17, 2024 | msn.com

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

April 17, 2024 | msn.com

What Is Pink Noise and How Does It Help You Sleep?

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

April 17, 2024 | finance.yahoo.com

Awakn Life Sciences Announces Closing of Tranche of Private Placement

April 17, 2024 | americanbankingnews.com

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Sees Significant Decrease in Short Interest

April 9, 2024 | msn.com

Older Floridians are going back to work as life gets less affordable

April 9, 2024 | msn.com

RNA that doesn't age: Neuroscientists discover building blocks in nerve cells that last a life time

April 5, 2024 | msn.com

Joanna Goddard Loves a Smash and Grab

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

April 4, 2024 | benzinga.com

ATAI Life Sciences Stock (NASDAQ:ATAI), Analyst Ratings, Price Targets, Predictions

March 26, 2024 | dailymail.co.uk

Singaporean-flagged container ship Dali told Baltimore authorities it had 'lost control' and was heading towards the bridge moments before it smashed into support pillar and ...

March 26, 2024 | msn.com

“That’s Just Not True”: A Hospice Nurse Is Debunking Myths And Answering All The Hard Questions About Death And Dying

March 22, 2024 | msn.com

Fentanyl killer who ‘hacked into the lives’ of married couple poisoned victim for 18 months

March 20, 2024 | msn.com

Medical Moment: Awake during brain surgery

March 15, 2024 | finance.yahoo.com

Canadian Securities Exchange Reports February 2024 Performance Figures

February 16, 2024 | benzinga.com

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More

February 13, 2024 | finance.yahoo.com

Canadian Securities Exchange Welcomes Listing of Awakn Life Sciences Corp

February 12, 2024 | finance.yahoo.com

Awakn Life Sciences Announces Listing on the Canadian Securities Exchange

February 5, 2024 | finanznachrichten.de

Awakn Life Sciences Corp.: Awakn Life Sciences Announces Conditional Approval of CSE Listing

February 5, 2024 | finance.yahoo.com

Awakn Life Sciences Announces Conditional Approval of CSE Listing

January 24, 2024 | finance.yahoo.com

Awakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers

January 4, 2024 | msn.com

Your January 2024 Horoscope Is Here, and It’s Time To Get After It

December 31, 2023 | morningstar.com

Awakn Life Sciences Corp AWKNF

December 21, 2023 | benzinga.com

Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation

December 20, 2023 | finance.yahoo.com

Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS

November 30, 2023 | msn.com

Perspective: The conflicting world views of Bryan Johnson and Ayaan Hirsi Ali

November 30, 2023 | seekingalpha.com

AWKNF Awakn Life Sciences Corp.

See More Headlines

Receive AWKNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Awakn Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:AWKNF
CUSIP: N/A
CIK: N/A
Web: awaknlifesciences.com
Phone: N/A
Fax: N/A
Employees: 44
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. George Scorsis (Age 46)
Co-founder & Chairman of the Board
Mr. Anthony Tennyson
Co-founder, President, CEO & Director
Mr. Jonathan James Held C.A. (Age 38)
CPA, CA, Interim CFO, Chief Business Officer & Secretary
Comp: $109.58k
Prof. David John Nutt DM
FMedSci, FRCP, FRCPsych, FSB, Ph.D., Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer

Key Competitors

View All Competitors

AWKNF Stock Analysis - Frequently Asked Questions

How have AWKNF shares performed in 2024?: Awakn Life Sciences' stock was trading at $0.1012 on January 1st, 2024. Since then, AWKNF shares have increased by 12.1% and is now trading at $0.1134.
View the best growth stocks for 2024 here.
Are investors shorting Awakn Life Sciences?: Awakn Life Sciences saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,000 shares, a drop of 9.1% from the March 15th total of 1,100 shares. Based on an average trading volume of 15,900 shares, the days-to-cover ratio is presently 0.1 days.
View Awakn Life Sciences' Short Interest.
How do I buy shares of Awakn Life Sciences?: Shares of AWKNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AWKNF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Awakn Life Sciences (AWKNF) Stock Price, News & Analysis

About Awakn Life Sciences Stock (OTCMKTS:AWKNF)

AWKNF Stock Price History

AWKNF Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

AWKNF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info